SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: E_K_S who wrote (66900)3/31/2021 8:37:04 AM
From: E_K_S2 Recommendations

Recommended By
CusterInvestor
RWS

  Read Replies (1) of 78957
 
Increased RKDA by 50% yesterday and then another 20% BUY pre-market AFTER Earnings this AM. An exciting story of a seed development company (a company created out of UC Davis). I have owned this for years watching their development and new patent seed varieties: Non-GMO Wheat amoung others.

Then This last Night! They finally post a profit


Lots of value in their seed patents and the company is/has developed Partnerships to grow their patent portfolio.

Arcadia Biosciences EPS beats by $1.31, beats on revenue
Mar. 30, 2021 4:10 PM ET Arcadia Biosciences, Inc. (RKDA)

Arcadia Biosciences (NASDAQ: RKDA): Q4 GAAP EPS of $0.90 beats by $1.31.Revenue of $7.13M (+1639.0% Y/Y) beats by $5.86M.Shares +29%

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2020 Financial Results and Business Highlights
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News